Celgene reveals plans to acquire Juno for $9bn

23-01-2018

Celgene reveals plans to acquire Juno for $9bn

designer491 / iStockphoto.com

Celgene and Juno Therapeutics announced yesterday that they have entered into a deal that will see Celgene acquire Juno.


Celgene Corporation, Juno Therapeutics, cancer treatment, Mark Alles, Hans Bishop, mergers & acquisitions,

LSIPR